Abstract
Rosacea is a chronic condition requiring long-term therapy for control and maintenance. Numerous controlled studies have shown that metronidazole 0.75% in combination with oral antibiotics significantly reduces the number of papules and pustules and erythema severity scores in patients with severe disease. Topical metronidazole 0.75% also maintains long-term remissions after oral tetracycline has been discontinued. Although original studies involving topical metronidazole 0.75% used a twice-daily regimen, subsequent work has shown that this formulation used once daily is as effective as 1% metronidazole.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies.Cutis. 2002;70:271–275.
Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea.J Am Acad Dermatol. 2002;46:584–587.
Rebora A. Rosacea.J Invest Dermatol. 1987;88(suppl 3):56S-60S.
Marks R, Harcourt-Webster JN. Histopathology of rosacea.Arch Dermatol. 1969;100:683–691.
Miyachi Y. Potential antioxidant mechanism of action for metronidazole: implications for rosacea management.Adv Ther. 2001;18:237–243.
Katz AM. Rosacea: epidemiology and pathogenesis.J Cutan Med Surg. 1998;2(suppl 4):S4–5–S4–9.
Wilkin JK. Rosacea. Pathophysiology and treatment.Arch Dermatol. 1994;130:359–362.
Miyachi Y. Pharmacologic modulation of neutrophil function.Clin Dermatol. 2000;18:369–373.
Bikowski JB. Rosacea: a tiered approach to therapy.Cutis. 2000;66(suppl 4):3–6.
Sneddon IB. A clinical trial of tetracycline in rosacea.Br J Dermatol. 1966;78:649–652.
Knight AG, Vickers CFH. A follow-up of tetracycline-treated rosacea.Br J Dermatol. 1975;93: 577–580.
Nielsen PG. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea.Br J Dermatol. 1983;109:63–65.
Nielsen PG. Treatment of rosacea with 1% metronidazole cream. A double-blind study.Br J Dermatol. 1983;108:327–332.
Aronson IK, Rumsfield JA, West DP, Alexander J, Fischer JH, Paloucek FP. Evaluation of topical metronidazole gel in acne rosacea.Drug Intell Clin Pharm. 1987;21:346–351.
Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea.Arch Dermatol. 1987;123:609–614.
Lowe NJ, Henderson T, Millikan LE, Smith S, Turk K, Parker F. Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial.Cutis. 1989;43:283–286.
Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.J Am Acad Dermatol. 2001;45:723–730.
Jorizzo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial.J Am Acad Dermatol. 1998;39:502–504.
Wagner N, Berthaud C, Laffet G, Caron JC. Differential penetration of skin by topical metronidazole formulations.Adv Ther. 1998;15:197–205.
Dahl MV, Katz I, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea.Arch Dermatol. 1998;134:679–683.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lowe, N.J. Use of topical metronidazole in moderate to severe rosacea. Adv Therapy 20, 177–190 (2003). https://doi.org/10.1007/BF02850088
Issue Date:
DOI: https://doi.org/10.1007/BF02850088